Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 701–800 of 1,011
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Akalin, A., Elmore, L. W., Forsythe, H. L., Amaker, B. A., McCollum, E. D., Nelson, P. S., Ware, J. L., & Holt, S. E. (2001) · PubMed · Cited by 90
Saqcena, M., Mukhopadhyay, S., Hosny, C., Alhamed, A., Chatterjee, A., & Foster, D. A. (2015) · Oncogene · doi:10.1038/onc.2014.207 · Cited by 67
Calderón‐Montaño, J. M., Martínez-Sánchez, S. M., Jiménez-González, V., Burgos‐Morón, E., Guillén-Mancina, E., Jiménez‐Alonso, J. J., Díaz-Ortega, P., García, F., Aparicio, A., & López‐Lázaro, M. (2021) · Plants · doi:10.3390/plants10102193 · Cited by 87
Elgort, M., O'Shea, J. M., Jiang, Y., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910389604 · Cited by 75
Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal Junction
Lagarde, S. M., ten Kate, F. J. W., Richel, D. J., Offerhaus, G. J. A., & van Lanschot, J. J. B. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9262-y · Cited by 66
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis
Güneş, Ç., Wezel, F., Southgate, J., & Bolenz, C. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0001-5 · Cited by 73
An oncogenic role for sphingosine kinase 2
Neubauer, H. A., Pham, D., Zebol, J. R., Moretti, P. A. B., Peterson, A. L., Leclercq, T. M., Chan, H., Powell, J. A., Pitman, M. R., Samuel, M. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11714 · Cited by 72
Phospholipase D Elevates the Level of MDM2 and Suppresses DNA Damage-Induced Increases in p53
Li, H., Abbas, T., Pielak, R. M., Joseph, T. W., Bargonetti, J., & Foster, D. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5677-5686.2004 · Cited by 71
Danielsson, F., Skogs, M., Huss, M., Rexhepaj, E., O’Hurley, G., Klevebring, D., Pontén, F., Gad, A. K. B., Uhlén, M., & Lundberg, E. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216436110 · Cited by 70
A Systems Biology Approach to Cancer: Fractals, Attractors, and Nonlinear Dynamics
Dinicola, S., D'Anselmi, F., Pasqualato, A., Proietti, S., Lisi, E., Cucina, A., & Bizzarri, M. (2011) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2010.0091 · Cited by 65
MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity
Liu, L., Ishihara, K., Ichimura, T., Fujita, N., Hino, S., Tomita, S., Watanabe, S., Saitoh, N., Ito, T., & Nakao, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807098200 · Cited by 71
Cheng, W., Su, Y., & Xu, F. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-170 · Cited by 78
Functional genetics and experimental models of human cancer
Zhao, J. J., Roberts, T. M., & Hahn, W. C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.005 · Cited by 71
Self-citationMachitani, M., Yasukawa, M., Nakashima, J., Furuichi, Y., & Masutomi, K. (2020) · Cancer Science · doi:10.1111/cas.14618 · Cited by 64
Shtutman, M. S., Baig, M. S., Levina, E. M., Hurteau, G. J., Lim, C., Broude, E. V., Nikiforov, M. A., Harkins, T. T., Carmack, C. S., Ding, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103842108 · Cited by 69
DNA repair pathways and hereditary cancer susceptibility syndromes
Spry, M. L., Scott, T., Pierce, H., & D'Orazio, J. A. (2007) · Frontiers in bioscience · doi:10.2741/2380 · Cited by 74
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth
Baxendale, A. J., Dawson, C., Stewart, S. E., Mudaliar, V., Reynolds, G. M., Gordon, J., Murray, P. G., Young, L. S., & Eliopoulos, A. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208929 · Cited by 64
Chen, W., Dong, Q., Shin, K.-H., Kim, R. H., Oh, J.-E., Park, N., & Kang, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103812 · Cited by 70
A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates
Calabrese, P., & Shibata, D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-3 · Cited by 64
Nguyen, T. H., Mai, G., Villiger, P., Oberholzer, J., Salmon, P., Morel, P., Bühler, L., & Trono, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.036 · Cited by 53
Casein kinase 1α–dependent feedback loop controls autophagy in RAS-driven cancers
Cheong, J. K., Zhang, F., Chua, P. J., Bay, B. H., Thorburn, A., & Virshup, D. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78018 · Cited by 64
Transcriptome-scale RNase-footprinting of RNA-protein complexes
Ji, Z., Song, R., Huang, H., Regev, A., & Struhl, K. (2016) · Nature Biotechnology · doi:10.1038/nbt.3441 · Cited by 67
Islam, M. K., Jackson, P. J., Rahman, K. M., & Thurston, D. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2015-0017 · Cited by 64
Structure-activity relationships among guanine-quadruplex telomerase inhibitors
Neidle, S., Harrison, R. J., Reszka, A. P., & Read, M. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00065-0 · Cited by 65
Shuda, M., Chang, Y., & Moore, P. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.483 · Cited by 64
Wang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Li, L., McCormack, A. A., Nicholson, J. M., Fabarius, A. C., Hehlmann, R., Sachs, R. K., & DUESBERG, P. H. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.08.016 · Cited by 64
Ubiquitin Ligase RLIM Modulates Telomere Length Homeostasis through a Proteolysis of TRF1
Her, Y. R., & Chung, I. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806702200 · Cited by 64
Pini, A., Shemesh, R., Samuel, C. S., Bathgate, R. A. D., Zauberman, A., Hermesh, C., Wool, A., Bani, D., & Rotman, G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170977 · Cited by 73
mRNA stability and cancer: an emerging link?
Benjamin, D., & Moroni, C. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.10.1515 · Cited by 63
McDonald, E. R., & El‐Deiry, W. S. (2001) · Annals of Medicine · doi:10.3109/07853890109002066 · Cited by 70
K-Ras Mutations and Benign Pancreatic Disease
Löhr, M. J., Maisonneuve, P., & Lowenfels, A. B. (2000) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:27:2:093 · Cited by 68
Perez, S., Vial, E., van Dam, H., & Castellazzi, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204200 · Cited by 70
Yildiz, G., Arslan-Ergul, A., Bagislar, S., Konu, O., Yuzugullu, H., Gursoy-Yuzugullu, O., Ozturk, N., Ozen, C., Ozdag, H., Erdal, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064016 · Cited by 62
Growth, Survival and Migration: The Trk to Cancer
Rubin, J. B., & Segal, R. A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_1 · Cited by 66
Simpson, N. E., Lambert, W. M., Watkins, R., Giashuddin, S., Huang, S. J., Oxelmark, E., Arju, R., Hochman, T., Goldberg, J. D., Schneider, R. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1590 · Cited by 61
Role of telomere in endothelial dysfunction in atherosclerosis
Minamino, T., & Komuro, I. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00010 · Cited by 74
Anti-Cancer Immunotherapies Targeting Telomerase
Negrini, S., Palma, R. D., & Filaci, G. (2020) · Cancers · doi:10.3390/cancers12082260 · Cited by 68
Casillas, M. A., Brotherton, S. L., Andrews, L. G., Ruppert, J. M., & Tollefsbol, T. O. (2003) · Gene · doi:10.1016/s0378-1119(03)00739-x · Cited by 51
Matsumura, N., Mandai, M., Miyanishi, M., Fukuhara, K., Baba, T., Higuchi, T., Kariya, M., Takakura, K., & Fujii, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2003 · Cited by 62
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
Chang, S. S., Khoo, C., & DePinho, R. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0374 · Cited by 71
Matsuda, Y. (2019) · Pathology International · doi:10.1111/pin.12837 · Cited by 61
Recent Patents on Anti-Telomerase Cancer Therapy
Agrawal, A., Dang, S., & Gabrani, R. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212798357958 · Cited by 61
Kennedy, A. L., McBryan, T., Enders, G. H., Johnson, F. B., Zhang, R., & Adams, P. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-16 · Cited by 61
“Regardless of the basis for these differences, it will ultimately be important to determine whether the relative ease of transformation of mouse cells, compared to human cells [28,29], stems, at least in part, from their Figure 4 Senescent MEFs do not downregulate expression of”
BackgroundMutational spectrum of Barrett’s stem cells suggests paths to initiation of a precancerous lesion
Yamamoto, Y., Wang, X., Bertrand, D., Kern, F., Zhang, T., Dulęba, M., Srivastava, S., Khor, C. C., Hu, Y., Wilson, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms10380 · Cited by 72
Fenoglio, D., Traverso, P., Parodi, A., Tomasello, L., Negrini, S., Kalli, F., Battaglia, F., Ferrera, F., Sciallero, S., Murdaca, G., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1415-9 · Cited by 69
Martini, F., Corallini, A., Balatti, V., Sabbioni, S., Pancaldi, C., & Tognon, M. G. (2007) · Infectious Agents and Cancer · doi:10.1186/1750-9378-2-13 · Cited by 61
Looijenga, L. H. J., Gillis, A., Stoop, H., Hersmus, R., & Oosterhuis, J. W. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00765.x · Cited by 61
Zhou, X. Z., Huang, P., Shi, R., Lee, T. H., Lu, G. H., Zhang, Z., Bronson, R. T., & Lu, K. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43452 · Cited by 64
Telomerase as a universal tumor antigen for cancer vaccines
Beatty, G. L., & Vonderheide, R. H. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.881 · Cited by 72
Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors
Henssen, A. G., Reed, C., Jiang, E., García, H. D., von Stebut, J., MacArthur, I. C., Hundsdoerfer, P., Kim, J. H., de Stanchina, E., Kuwahara, Y., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam9078 · Cited by 64
Co-polymers of Actin and Tropomyosin Account for a Major Fraction of the Human Actin Cytoskeleton
Meiring, J. C. M., Bryce, N. S., Wang, Y., Taft, M. H., Manstein, D. J., Lau, S. L., Stear, J. H., Hardeman, E. C., & Gunning, P. W. (2018) · Current Biology · doi:10.1016/j.cub.2018.05.053 · Cited by 59
Copper chaperone ATOX1 is required for MAPK signaling and growth in BRAF mutation-positive melanoma
Kim, Y., Bond, G. J., Tsang, T., Posimo, J. M., Busino, L., & Brady, D. C. (2019) · Metallomics · doi:10.1039/c9mt00042a · Cited by 63
Musio, A., Montagna, C., Zambroni, D., Indino, E., Barbieri, O., Citti, L., VILLA, A. M., Ried, T., & Vezzoni, P. (2003) · PubMed · Cited by 61
Jackson, J. B., & Pallas, D. C. (2012) · Neoplasia · doi:10.1593/neo.12768 · Cited by 60
Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
Visnes, T., Benitéz‐Buelga, C., Cázares‐Körner, A., Sanjiv, K., Hanna, B., Mortusewicz, O., Rajagopal, V., Albers, J. J., Hagey, D. W., Bekkhus, T., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1048 · Cited by 69
Genetic induction of tumorigenesis in Swine
Adam, S. J., Rund, L. A., Kuzmuk, K. N., Zachary, J. F., Schook, L. B., & Counter, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209892 · Cited by 60
Self-citationGreatwall promotes cell transformation by hyperactivating AKT in human malignancies
Vera, J., Lartigue, L., Vigneron, S., Gadéa, G., Gire, V., Rio, M. D., Soubeyran, I., Chibon, F., Lorca, T., & Castro, A. (2015) · eLife · doi:10.7554/elife.10115 · Cited by 62
Gaebler, M., Silvestri, A., Haybaeck, J., Reichardt, P., Lowery, C. D., Stancato, L. F., Zybarth, G., & Regenbrecht, C. R. A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00203 · Cited by 63
The non-canonical functions of telomerase: to turn off or not to turn off
Romaniuk-Drapała, A., Paszel-Jaworska, A., Totoń, E., Lisiak, N., Hołysz, H., Królak, A., Grodecka-Gazdecka, S., & Rubiś, B. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4496-x · Cited by 71
Taylor, S. E., O'Connor, C. M., Wang, Z., Shen, G., Song, H., Leonard, D., Sangodkar, J., LaVasseur, C., Avril, S., Waggoner, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0218 · Cited by 59
Martin, A. P., Jacquemyn, M., Lipecka, J., Chhuon, C., Aushev, V. N., Meunier, B., Singh, M. K., Carpi, N., Piel, M., Codogno, P., et al. (2019) · EMBO reports · doi:10.15252/embr.201948150 · Cited by 59
Telomerase is regulated by protein kinase C-ζ in human nasopharyngeal cancer cells
Yu, C.-C., Shi-Ching, L. O., & Wang, T. V. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550459 · Cited by 66
Vécsey-Semjén, B., Becker, K., Sinski, A., Blennow, E., Vietor, I., Zatloukal, K., Beug, H., Wagner, E., & Huber, L. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205577 · Cited by 66
Telomerase extracurricular activities
Chang, S., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212514699 · Cited by 60
Requirement of DDX39 DEAD box RNA helicase for genome integrity and telomere protection
Yoo, H. H., & Chung, I. K. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00696.x · Cited by 68
Implications of telomere‐independent activities of telomerase reverse transcriptase in human cancer
Ding, D., Zhou, J., Wang, M., & Cong, Y. (2013) · FEBS Journal · doi:10.1111/febs.12258 · Cited by 70
Beuster, G., Zarse, K., Kaleta, C., Thierbach, R., Kiehntopf, M., Steinberg, P., Schuster, S., & Ristow, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.205229 · Cited by 67
Expansion of functional personalized cells with specific transgene combinations
Lipps, C., Klein, F., Wahlicht, T., Seiffert, V., Butueva, M., Zauers, J., Truschel, T., Luckner, M., Köster, M., MacLeod, R. A. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03408-4 · Cited by 70
Sharma, R., Brown, D., Awasthi, S., Yang, Y., Sharma, A., Patrick, B., Saini, M. K., Singh, S. P., Zimniak, P., Singh, S. V., et al. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04067.x · Cited by 61
Martinelli, M., Martini, F., Rinaldi, E., Caramanico, L., Magri, E., Grandi, E., Carinci, F., Pastore, A. L., & Tognon, M. G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64389-1 · Cited by 59
Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process
Yagüe, E., Arance, A. M., Kubitza, L., O’Hare, M. J., Jat, P., Ogilvie, C. M., Hart, I. R., Higgins, C. F., & Raguz, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2574 · Cited by 66
Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during Quiescence
Litovchick, L., Chestukhin, A., & DeCaprio, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8970-8980.2004 · Cited by 59
A decade of tyrosine kinases: from gene discovery to therapeutics
Craven, R. J., Lightfoot, H. M., & Cance, W. G. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00004-5 · Cited by 66
Sarcoma Stem Cell Heterogeneity
Hatina, J., Kripnerová, M., Houfková, K., Pešta, M., Kuncová, J., Šáňa, J., Slabý, O., & Rodrı́guez, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11096-3_7 · Cited by 58
The Minimal Active Structure of Human Relaxin-2
Hossain, M. A., Rosengren, K. J., Samuel, C. S., Shabanpoor, F., Chan, L. J., Bathgate, R. A. D., & Wade, J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282194 · Cited by 58
Desai, P. J., Sexton, G. L., Huang, E. Y., & Person, S. (2008) · Journal of Virology · doi:10.1128/jvi.00956-08 · Cited by 58
Li, H., Wang, W., Liu, X., Paulson, K. E., Yee, A. S., & Zhang, X. (2010) · Oncogene · doi:10.1038/onc.2010.252 · Cited by 68
On the karyotypic origin and evolution of cancer cells
Nicholson, J. M., & DUESBERG, P. H. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.06.008 · Cited by 71
Mechanisms of oncogenic cooperation in cancer initiation and metastasis.
Pedraza, L. G. (2006) · PubMed Central · Cited by 58
Investigation of Adenovirus Occurrence in Pediatric Tumor Entities
Kosulin, K., Haberler, C., Hainfellner, J. A., Amann, G., Lang, S., & Lion, T. (2007) · Journal of Virology · doi:10.1128/jvi.00355-07 · Cited by 58
Recent Developments on Human Cell Lines for the Bioartificial Liver
Hoekstra, R., & Chamuleau, R. A. F. M. (2002) · The International Journal of Artificial Organs · doi:10.1177/039139880202500304 · Cited by 58
The fabric of cancer cell biology—Weaving together the strands
Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00020-x · Cited by 57
The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis
Köhn‐Gaone, J., Gogoi-Tiwari, J., Ramm, G. A., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2015 · Cited by 62
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Drummond, M. W., Balabanov, S., Holyoake, T. L., & Brümmendorf, T. H. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0057 · Cited by 64
Li, H., Rodrik-Outmezguine, V. S., Pielak, R. M., Knirr, S., Yang, Z., & Foster, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504192200 · Cited by 62
Ding, L., Li, L. L., Yang, H. J., Tao, Y. G., Ye, M., Shi, Y., Tang, M., Wei, Y., Li, X. L., Gong, J. P., et al. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.012 · Cited by 64
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer
Filaci, G., Fravega, M., Setti, M., Traverso, P., Millo, E., Fenoglio, D., Negrini, S., Ferrera, F., Romagnoli, A., Basso, M., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0258 · Cited by 65
Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells
Shlyakhtina, Y., Pavet, V., & Gronemeyer, H. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.423 · Cited by 56
Blüthgen, N., Legewie, S., Kiełbasa, S. M., Schramme, A., Tchernitsa, O. I., Keil, J., Solf, A., Vingron, M., Schäfer, R., Herzel, H., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06846.x · Cited by 64
The microenvironments of multistage carcinogenesis
Laconi, E., Doratiotto, S., & Vineis, P. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.019 · Cited by 61
Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts
Nguyen, C. L., Possemato, R., Bauerlein, E. L., Xie, A., Scully, R., & Hahn, W. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00436-12 · Cited by 68
Self-citationFisher, K. W., Das, B., Kortum, R. L., Chaika, O. V., & Lewis, R. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05255-11 · Cited by 67
Ohba, S., Mukherjee, J., Johannessen, T.-C., Mancini, A., Chow, T. T., Wood, M., Jones, L., Mazor, T., Marshall, R. E., Viswanath, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0696 · Cited by 56
Schreurs, M. W. J., Scholten, K. B. J., Taanman-Kueter, E. W., Ruizendaal, J. J., Meijer, C. J. L. M., & Hooijberg, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2912 · Cited by 57
Milyavsky, M., Tabach, Y., Shats, I., Erez, N., Cohen, Y., Tang, X., Kalis, M., Kogan, I., Buganim, Y., Goldfinger, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3880 · Cited by 56
Moreno, C. S., Ramachandran, S., Ashby, D. G., Laycock, N., Plattner, C. A., Chen, W., Hahn, W. C., & Pallas, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1150 · Cited by 56
Self-citationRegulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence
Akare, S., Jean‐Louis, S., Chen, W., Wood, D. J., Powell, A. A., & Martinez, J. D. (2006) · International Journal of Cancer · doi:10.1002/ijc.22231 · Cited by 55
Telomere and telomerase in chronic liver disease and hepatocarcinoma
Carulli, L., & Anzivino, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6287 · Cited by 57
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.